Eliquis more effective at preventing strokes in patients with atrial fibrillation

The experimental anticlotting pill Eliquis beat out the standard drug, warfarin, at preventing strokes in people with a heart condition that puts them at high risk of blood clots and stroke, researchers report. The new drug, also known as apixaban, cut the risk of stroke by 21% compared with warfarin in people with atrial fibrillation (AF). It lowered the risk of dying by 11%. The side effect of serious internal bleeding, the key safety concern of anticlotting medication, was reduced by 31% with Eliquis compared to warfarin - WebMD